PFE Pfizer Inc. Stock Quote

PFE [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	11.36	EPS (ttm)	4.43	Insider Own	0.04%	Shs Outstand	5.62B	Perf Week	1.92%
Market Cap	285.45B	Forward P/E	9.51	EPS next Y	5.30	Insider Trans	-11.70%	Shs Float	5.54B	Perf Month	0.44%
Income	25.42B	PEG	-	EPS next Q	1.98	Inst Own	68.50%	Short Float	1.23%	Perf Quarter	1.45%
Sales	92.37B	P/S	3.09	EPS this Y	233.60%	Inst Trans	0.30%	Short Ratio	2.41	Perf Half Y	1.61%
Book/sh	14.67	P/B	3.44	EPS next Y	-22.36%	ROA	14.00%	Target Price	59.33	Perf Year	26.54%
Cash/sh	4.22	P/C	11.95	EPS next 5Y	-0.80%	ROE	32.70%	52W Range	38.47 - 61.71	Perf YTD	-14.65%
Dividend	1.60	P/FCF	12.42	EPS past 5Y	27.40%	ROI	18.90%	52W High	-18.89%	Beta	0.73
Dividend %	3.17%	Quick Ratio	1.10	Sales past 5Y	9.00%	Gross Margin	60.40%	52W Low	30.08%	ATR	1.46
Employees	79000	Current Ratio	1.40	Sales Q/Q	76.80%	Oper. Margin	30.30%	RSI (14)	49.00	Volatility	2.66% 2.96%
Optionable	Yes	Debt/Eq	0.44	EPS Q/Q	58.80%	Profit Margin	27.00%	Rel Volume	0.55	Prev Close	50.40
Shortable	Yes	LT Debt/Eq	0.43	Earnings	May 03 BMO	Payout	35.30%	Avg Volume	28.18M	Price	50.05
Recom	-	SMA20	1.15%	SMA50	-2.28%	SMA200	0.60%	Volume	5,538,025	Change	-0.69%

Apr-06-22

Resumed

Morgan Stanley

Equal-Weight

$55

Jan-05-22

Upgrade

BofA Securities

Neutral → Buy

$59 → $70

Jan-03-22

Reiterated

Bernstein

Mkt Perform

$44 → $65

Dec-20-21

Reiterated

Cowen

Outperform

$56 → $70

Dec-17-21

Initiated

Goldman

Neutral

$51

Dec-13-21

Upgrade

UBS

Neutral → Buy

$52 → $60

Dec-09-21

Initiated

Wells Fargo

Overweight

$60

Nov-19-21

Initiated

BMO Capital Markets

Outperform

$60

Jul-27-21

Resumed

Truist

Buy

$43

May-06-21

Downgrade

Mizuho

Buy → Neutral

$42

Apr-07-21

Resumed

RBC Capital Mkts

Sector Perform

$42

Feb-04-21

Upgrade

DZ Bank

Hold → Buy

$41

Dec-16-20

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$43 → $42

Nov-19-20

Resumed

Goldman

Neutral

$40

Nov-10-20

Resumed

Bernstein

Mkt Perform

$42

Oct-12-20

Downgrade

Atlantic Equities

Overweight → Neutral

$44 → $39

Sep-29-20

Initiated

Berenberg

Hold

$38

Jun-16-20

Initiated

SVB Leerink

Mkt Perform

$40

Feb-27-20

Upgrade

Standpoint Research

Hold → Buy

Feb-27-20

Initiated

Barclays

Equal Weight

$36

May-19-22 11:37AM	UPDATE 1-EU health regulator backs using AstraZeneca COVID shot as booster Reuters
06:20AM	Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? Zacks
May-18-22 12:21PM	REFILE-U.S. to study whether longer Paxlovid course needed to combat reinfections Reuters
11:53AM	Why Pfizer Looks Better Than Moderna as a Long-Term Buy Motley Fool
10:10AM	Moderna (MRNA) Stock Rises 4%: What's Behind the Upside? Zacks
10:07AM	Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children Zacks
09:39AM	10 Best Vanguard Dividend Stocks with High Yields Insider Monkey
06:30AM	Is Ocugen Finally on the Way to Vaccine Revenue? Motley Fool
02:56AM	From storage to transport, hurdles to getting COVID vaccine to N.Koreans Reuters
May-17-22 04:01PM	Pfizer Retakes A Key Line And Drags BioNTech, Moderna With It Investor's Business Daily
04:00PM	FDA Gives Green Signal To Pfizer/BioNTech's COVID-19 Booster For Kids 5-11 Years Benzinga
03:52PM	Why BioNTech Stock Jumped Today Motley Fool
03:41PM	Citi stock up after Berkshire discloses $3 billion stake, FDA approves Pfizer booster for ages 5-11 Yahoo Finance Video
02:55PM	UPDATE 3-As U.S. COVID-19 cases rise, so does demand for antivirals Reuters
11:40AM	Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age Business Wire
11:27AM	The Zacks Analyst Blog Highlights NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce Zacks
11:15AM	U.S. government is offering free COVID tests again, as cases rise 57% from two weeks ago; FDA authorizes booster for children aged 5 to 11 MarketWatch
11:08AM	FDA authorizes a booster dose of BioNTech/Pfizer's vaccine for 5 to 11 year olds MarketWatch
10:57AM	FDA Clears Pfizer Covid Booster for Kids Aged 5 to 11 Barrons.com
10:55AM	Pfizer, BioNTech Rise After FDA Approves Covid Boosters for Children Investing.com
10:24AM	UPDATE 3-U.S. FDA authorizes Pfizer's COVID booster shot for young children Reuters
10:17AM	U.S. FDA authorizes Pfizer's COVID booster shot for young children Reuters
08:45AM	Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned? Motley Fool
07:26AM	FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT Benzinga
May-16-22 04:31PM	Is Pfizer Stock A Buy As 2022 Covid Vaccine Sales Appear Front-Loaded? Investor's Business Daily
04:30PM	UPDATE 3-FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT Reuters
04:26PM	Is AbbVie Stock A Buy As Humira Biosimilar Rivals Loom? Investor's Business Daily
03:37PM	What you hear in DC doesn't reflect what's going across the US: Fmr. US Surgeon General Yahoo Finance
02:53PM	Top Analyst Reports for NVIDIA, Home Depot, Pfizer & Others Zacks
07:34AM	Pfizer/BioNTech COVID-19 Vaccine's European Delivery Takes Backseat To Help Booster Campaign Benzinga
07:00AM	This Fund Rarely Rebalances But It's Clobbering The Market Investor's Business Daily
May-14-22 10:30AM	3 Supercharged Dividend Stocks to Buy in the Stock Market Sell-Off Motley Fool
07:04AM	3 Dirt-Cheap Stocks You Can Buy Right Now Motley Fool
May-13-22 05:37PM	UPDATE 1-Pfizer, EU push back COVID vaccine delivery to help booster campaign Reuters
02:08PM	Biden Says US Ready To Share COVID-19 Vaccine Related Technology Benzinga
01:44PM	Stock rebound uncertain for U.S. biotechs as risks multiply for investors American City Business Journals
10:41AM	Some patients and physicians say its hard to find Paxlovid, Pfizers COVID-19 pill MarketWatch
08:10AM	Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update Zacks
07:00AM	7 Cheap Stocks to Buy Now for a Rich Retirement InvestorPlace
May-12-22 04:56PM	Pfizer Turns to Unusual Deal Structure to Buy Biohaven Drugs Bloomberg
03:41PM	Price Of Pfizer's Paxlovid Generic Version Capped At $25 Or Less For Low-Income Countries Benzinga
03:09PM	Misinformation Proliferates Surrounding Pfizer Vaccine Investopedia
10:25AM	A Healthcare Revolution Is Coming. How to Invest. Barrons.com
10:00AM	Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries Reuters
10:00AM	Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress PR Newswire
08:02AM	Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID Zacks
02:45AM	A Healthcare Revolution Is Coming. Heres How to Invest. Barrons.com
May-11-22 02:12PM	Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider Zacks
02:08PM	Exelixis (EXEL) Q1 Earnings Beat, Revenues Miss Estimates Zacks
01:16PM	Pfizer's $11.6 billion Biohaven buy could spark more biotech deals Reuters
01:12PM	Pfizer's $11.6 bln Biohaven buy could spark more biotech deals Reuters
07:00AM	EXPLAINER-Some patients reporting COVID rebounds after taking Pfizer pills Reuters
May-10-22 09:00PM	Pfizer is Acquiring a Migraine Fixer for $11.6 Billion Motley Fool
04:06PM	Pfizer Buys Biohaven In A $12 Billion Deal That 'Couldn't Have Come At A Better Time' Investor's Business Daily
02:47PM	Novavax (NVAX) Down on Q1 Earnings and Sales Lagging Estimates Zacks
02:26PM	Pfizer Is Spending $11.6 Billion on Biohaven. Its Plans Point to a Lot More M&A. Barrons.com
12:06PM	Pfizer to Buy Rest of Biohaven for $11.6 Billion The Wall Street Journal
12:04PM	Stock Market Fades, Mixed At Midday; A Defensive Group Sells Off Investor's Business Daily
11:33AM	Pfizer to Acquire Biohaven Pharmaceutical for $11.6 Billion Bloomberg
11:28AM	Rare cases of COVID patients relapsing pose questions for Pfizers Paxlovid MarketWatch
11:23AM	WHO calls on Pfizer to make its COVID pill more available The Independent
10:06AM	Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion Barrons.com
09:51AM	Pfizer acquires Biohaven for $11.6 billion in cash Yahoo Finance Video
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know Zacks
08:30AM	Pfizer Acquires This Migraine Drug Maker For $11B: What Investors Need To Know Benzinga
07:00AM	UPDATE 1-Pfizer to buy Biohaven Pharmaceutical in $11.6 bln deal Reuters
06:56AM	Pfizer to pay $11.6 billion for Biohaven to tap migraine market Reuters
06:56AM	Pfizer to acquire Biohaven Pharma for $11.6 billion in cash sending Biohaven shares up 74% premarket MarketWatch
06:52AM	Pfizer to buy biotech group BioHaven for $11.8bn Financial Times
06:45AM	Pfizer to Acquire Biohaven Pharmaceuticals Business Wire
06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks
May-09-22 04:10PM	BioNTech's Revenue Triples On Omicron Demand For Its Pfizer-Partnered Covid Shot Investor's Business Daily
09:31AM	BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine Barrons.com
08:19AM	UPDATE 1-BioNTech's Q1 vaccine sales triple but it still flags full-year decline Reuters
06:45AM	BioNTech Pushes Toward Omicron-Adapted Booster as Sales Soar Bloomberg
06:15AM	BioNTech earnings jump after 750 million COVID vaccines invoiced MarketWatch
06:11AM	BioNTech's Q1 vaccine sales triple but it still flags full-year decline Reuters
06:00AM	COVID vaccine makers shift focus to boosters Reuters
06:00AM	BioNTech posts tripled Q1 vaccine sales but still flags full-year decline Reuters
May-07-22 08:25AM	Here's What We Like About Pfizer's (NYSE:PFE) Upcoming Dividend Simply Wall St.
08:07AM	2 Healthcare Stocks That Could Make You Richer Motley Fool
07:03AM	3 Unstoppable Stocks to Buy in May Motley Fool
May-06-22 04:15PM	Theravance's (TBPH) Q1 Earnings and Sales Miss Estimates Zacks
01:13PM	COVID SCIENCE-Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from variants Reuters
11:30AM	Is Pfizer Too Dependent on COVID-19 Revenue? Motley Fool
10:45AM	3 Top Biotech Stocks to Buy Right Now Motley Fool
10:07AM	Nektar's (NKTR) Q1 Earnings Top, Workforce Reduction on Track Zacks
09:02AM	10 Biotech Penny Stocks Redditors Love Insider Monkey
06:56AM	Coronavirus tally: FDA limits who can get J&J COVID vaccine over rare blood clot issue MarketWatch
06:45AM	Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis GlobeNewswire
06:39AM	FDA limits use of J&J COVID-19 vaccine over blood clot concerns Yahoo Finance
May-05-22 06:12PM	Evidence mounts for need to study Pfizer's Paxlovid for long COVID - researchers say Reuters
11:11AM	Pfizer's COVID Treatment Pill Falls Short Investopedia
10:04AM	UPDATE 1-EU regulator hopes to approve COVID variant-adapted vaccines by autumn Reuters
07:36AM	Pfizer is looking beyond the COVID-19 market, aiming to be the partner of choice for biotech MarketWatch
05:55AM	Pfizer Is Poised to Shatter These 2 Records in 2022 Motley Fool
May-04-22 04:39PM	Vaccine Makers Slump as Moderna, Pfizer Leave Full-Year Guidance Intact Bloomberg
10:11AM	Moderna CEO talks huge earnings beat, COVID-19 vaccine sales, new boosters Yahoo Finance Video
07:04AM	Moderna sees higher COVID vaccine sales later this year Reuters
07:04AM	Moderna sees higher COVID vaccine sales in second half of 2022 Reuters

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	May 16	Sale	50.50	4,000	202,000	15,064	May 17 07:48 AM
SAHNI PAYAL	Executive Vice President	May 13	Sale	49.84	1,408	70,175	17,372	May 16 09:23 PM
Carapezzi William R JR	Executive Vice President	May 12	Sale	50.00	32,908	1,645,400	38,146	May 13 05:38 PM
LANKLER DOUGLAS M	Executive Vice President	May 12	Sale	49.41	38,273	1,891,069	78,803	May 13 05:19 PM
Dolsten Mikael	President R&D	May 11	Sale	49.32	63,902	3,151,547	333,342	May 12 04:34 PM
Dolsten Mikael	President R&D	Mar 03	Option Exercise	31.83	102,460	3,261,036	396,578	Mar 04 04:13 PM
DAMELIO FRANK A	Executive Vice President	Feb 26	Option Exercise	25.60	127,160	3,255,296	649,918	Mar 01 05:55 PM
SUSMAN SALLY	Executive Vice President	Feb 26	Option Exercise	25.60	63,580	1,627,648	172,880	Mar 01 05:55 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 26	Option Exercise	25.60	9,713	248,653	26,120	Mar 01 04:02 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 26	Option Exercise	25.60	77,709	1,989,350	174,507	Mar 01 04:03 PM
McDermott Michael	Executive Vice President	Feb 26	Option Exercise	25.60	12,340	315,904	83,530	Mar 01 04:03 PM
Carapezzi William R JR	Executive Vice President	Feb 26	Option Exercise	25.60	21,193	542,541	87,363	Mar 01 04:03 PM
Carapezzi William R JR	Executive Vice President	Feb 23	Option Exercise	27.34	25,632	700,779	82,914	Feb 25 05:06 PM
SAHNI PAYAL	Executive Vice President	Feb 23	Option Exercise	27.34	13,884	379,589	29,391	Feb 25 06:27 PM
SUSMAN SALLY	Executive Vice President	Feb 23	Option Exercise	27.34	76,895	2,102,309	166,470	Feb 25 06:29 PM
Hwang Angela	Group President	Feb 23	Option Exercise	27.34	21,359	583,955	21,359	Feb 25 06:10 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23	Option Exercise	27.34	115,342	3,153,450	181,659	Feb 25 06:20 PM
DAMELIO FRANK A	Executive Vice President	Feb 23	Option Exercise	27.34	153,789	4,204,591	636,977	Feb 25 06:04 PM
JOHNSON RADY A	Executive Vice President	Feb 23	Option Exercise	27.34	35,457	969,394	91,301	Feb 25 06:17 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23	Option Exercise	27.34	11,748	321,190	21,668	Feb 25 05:46 PM
Dolsten Mikael	President R&D	Dec 17	Option Exercise	30.17	71,187	2,147,712	351,637	Dec 21 06:31 PM
BOURLA ALBERT	Chairman & CEO	Dec 17	Option Exercise	26.73	123,055	3,289,547	246,444	Dec 21 06:03 PM
JOHNSON RADY A	Executive Vice President	Dec 03	Sale	53.42	19,000	1,015,042	55,844	Dec 06 05:18 PM
MACKENZIE ALEXANDER R	Executive Vice President	Dec 02	Sale	54.26	41,360	2,244,194	87,280	Dec 06 05:18 PM
SUSMAN SALLY	Executive Vice President	Nov 26	Sale	54.52	44,308	2,415,578	89,575	Nov 30 04:30 PM
LANKLER DOUGLAS M	Executive Vice President	Nov 26	Sale	54.37	40,000	2,174,786	66,317	Nov 30 04:30 PM
Hwang Angela	Group President	Nov 12	Sale	49.60	26,170	1,298,002	1	Nov 15 05:32 PM
Dolsten Mikael	President R&D	Nov 11	Option Exercise	25.13	199,548	5,014,926	339,506	Nov 15 05:40 PM
Dolsten Mikael	President R&D	Nov 11	Sale	50.29	59,664	3,000,647	279,842	Nov 15 05:40 PM
YOUNG JOHN D	Group President	Nov 11	Sale	50.06	150,000	7,508,732	312,704	Nov 12 06:08 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13	Sale	48.30	1,661	80,226	9,769	Aug 16 08:12 PM
DAMICO JENNIFER B.	SVP & Controller	Jul 30	Sale	42.86	2,500	107,150	11,430	Aug 02 07:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience